LexDanaLexDanabeta
Inventor

Peter J. Connolly

Inventor
New Providence, NJ, US

Overview

63→
Patents
1992–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 63 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds44%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
A61KPreparations for medical, dental or toiletry purposes16%
C07CAcyclic or carbocyclic compounds4%
C07HSugars1%
C07KPeptides1%
PatentTitleYear
11,040,031Pyrazole derivatives as MALT1 inhibitors202111,021,511Cyclic dinucleotides as sting agonists202110,981,926Substituted thiohydantoin derivatives as androgen receptor antagonists202110,954,214Pyrazole derivatives as MALT1 inhibitors202110,888,550Pyrazole derivatives as MALT1 inhibitors202110,501,469Substituted thiohydantoin derivatives as androgen receptor antagonists201910,413,545Imidazolin-5-one derivative useful as FASN inhibitors for the treatment of cancer201910,077,261Imidazolin-5-one derivative useful as FASN inhibitors for the treatment of cancer201810,000,502Substituted thiohydantoin derivatives as androgen receptor antagonists20189,718,813'Imidazolin-5-one derivative useful as FASN inhibitors for the treatment of cancer'20179,562,035'Benzamide derivative useful as FASN inhibitors for the treatment of cancer'20178,962,607'Azetidinyl diamides as monoacylglycerol lipase inhibitors'20158,846,655'4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators'20148,778,956'Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders'20148,759,333'Di-azetidinyl diamide as monoacylglycerol lipase inhibitors'20148,759,533'Di-azetidinyl diamide as monoacylglcerol lipase inhibitors'20148,748,417'Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitors'20148,722,658'Azetidinyl diamides as monoacylglycerol lipase inhibitors'20148,697,683'Azetidinyl diamides as monoacylglycerol lipase inhibitors'20148,685,990'Pyrimidine compounds as delta opioid receptor modulators'20148,637,498'Oxopiperazine-azetidine amides and oxodiazepine-azetidine amides as monoacylglycerol lipase inhibitors'20148,575,363'Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitors'20138,513,271'Pyrimidine compounds as delta opioid receptor modulators'20138,513,423'Piperidin-4-yl-azetidine diamides as monoacylglycerol lipase inhibitors'20138,367,825'Substituted pyrimidinyl oxime kinase inhibitors'20138,314,234'Bicyclic pyrimidine kinase inhibitors'20128,299,082'1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives'20128,293,750'Pyrazines as delta opioid receptor modulators'20128,278,446'Process for preparing substituted diaminopyrimidine oximes'20128,183,371'Pyrazines as delta opioid receptor modulators'20128,153,791'Substituted pyrimidinyl oxime kinase inhibitors'20128,013,153'Substituted pyrimidine kinase inhibitors'20117,888,380'1,2,4-Triazolylaminoaryl (heteroaryl) sulfonamide derivatives'20117,855,205'Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders'20107,659,284'Thiazolopyridine kinase inhibitors'20107,655,670'3-spirocyclic indolyl derivatives useful as ORL-1 receptor modulators'20107,638,518'Substituted pyrazole kinase inhibitors'20097,635,703'Imidazole substituted pyrazole kinase inhibitors'20097,605,154'Substituted Thiazolo [4,5-d]pyrimidines as protein kinase inhibitors'20097,582,649'Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders'20097,579,356'Thia-tetraazaacenaphthylene kinase inhibitors'20097,541,367'3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders'20097,517,885'Substituted [4-(4-phenyl-piperazin-1-yl)-cyclohexyl]-urea compounds'20097,482,348'Piperazinyl substituted cyclohexane-1,4-diamines'20097,470,711'Piperidinyl substituted cyclohexane-1,4-diamines'20087,459,557'Substituted isoindole-1,3-diones'20087,427,625'Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors'20087,384,979'Substituted amino acids as erythropoietin mimetics'20087,317,031'Substituted triazole diamine derivatives as kinase inhibitors'20087,153,869'Substituted amino acids as erythropoietin mimetics'20067,109,220'Amino substituted pyridinyl methanone compounds useful in treating kinase disorders'20067,081,463'Hydroxy alkyl substituted 1,3,8-Triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1receptor mediated disorders'20066,924,302'Substituted triazole diamine derivatives as kinase inhibitors'20056,828,327'Macroheterocylic compounds useful as kinase inhibitors'20046,750,369'Substituted amino acids as erythropoietin mimetics'20046,710,048'Pyrazine derivatives as modulators of tyrosine kinases'20046,310,078'Substituted amino acids as erythropoietin mimetics'20016,028,202'1,5-diarylpyrazoles'20005,925,769'Acetylenic 1,5-diarylpyrazoles as antiinflammatory agents'19995,387,693'Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole intermediate compounds'19955,315,012'Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds'19945,250,561'Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds and their use as HMG-COA reductase inhibitors'19935,134,155'Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds and their use as HMG-coA reductase inhibitors'1992

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1992–2000Patents assigned to ORTHO PHARMA CORP (6)· patent assignee history
1992–1994Based in Morristown, NJ, US· patent location history
1995–2021Based in New Providence, NJ, US· patent location history
2001–2008Patents assigned to ORTHO MCNEIL PHARM INC (7)· patent assignee history
2006–2021Patents assigned to JANSSEN PHARMACEUTICA NV (48)· patent assignee history
2006–2014Patents assigned to CONNOLLY PETER J (14)· patent assignee history
2012–2014Patents assigned to MACIELAG MARK J (7)· patent assignee history
2014Based in Spring House, PA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
JANSSEN PHARMACEUTICA NV482006–2021
CONNOLLY PETER Jself142006–2014
MACIELAG MARK J72012–2014
ORTHO MCNEIL PHARM INC72001–2008
ORTHO PHARMA CORP61992–2000
Locations
LocationPatentsSpan
New Providence, New Jersey, US591995–2021
Morristown, New Jersey, US31992–1994
Spring House, Pennsylvania, US12014